John A. Reynolds

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim et al. · The Lancet Oncology · 2018 · 568 citations · Full text

Medicine, Immunology, Pathology +5

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

C. J. Peters, John A. Reynolds, T. W. Slone et al. · Antiviral Research · 1986 · 144 citations

Vaccination, Immune Serum, Immunology +8

Glucan-induced enhancement of host resistance to selected infectious diseases

John A. Reynolds, M. D. Kastello, D. G. Harrington et al. · Infection and Immunity · 1980 · 142 citations · Full text

Veterinary Vaccine, Susceptible Host, Intranasal Glucan Pretreatment +16

Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort

Christine Chew, John A. Reynolds, Apinya Lertratanakul et al. · Lara D. Veeken · 2021 · 101 citations · Full text

25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus

John A. Reynolds, S. Haque, J. L. Berry et al. · Lara D. Veeken · 2011 · 88 citations · Full text